Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Pancreatic Neoplasms 2Mesothelioma 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Turcot syndrome 1Stomach Neoplasms 1Solid Tumors 1Sarcoma 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Microsatellite Instability 1Mesothelioma, Malignant 1Mesothelin-positive Advanced Refractory Solid Tumors 1Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Advanced Solid Tumor 1

Interventions

Nivolumab 2regorafenib 1pembrolizumab 1fludarabine phosphate 1fludarabine 1Ipilimumab 1Interleukin-2 1Cyclophosphamide 1Clinical Trials, Phase II as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × fludarabine phosphate × Other solid neoplasm × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡